News & Events

Category:Research News

HIV care in the US sees big gains, but disparities remain

UW School of Public Health
September 7, 2018
Robin Nance, UW Biostat grad (MS ’04) and current doctoral student in epidemiology, is among the lead authors of this new study. She's credit with helping to develop the statistical models "that formed the backbone of the paper.”
Read article »

Dengue vaccine development taps new approach

UW News
August 25, 2018
There is a new, innovative approach to dengue vaccine development, according to a paper published Aug. 20 in the Proceedings of the National Academy of Sciences. Researchers at the Fred Hutchinson Cancer Research Center and University of Washington School of Public Health led the study.
Read article »

UW researchers contribute to international study finding genetic link to psychiatric disorders

UW Department of Epidemiology
June 27, 2018
UW Biostatistics researchers Ellen Wijsman and Kenneth Rice contributed to this study relating to similar gene variations in psychiatric brain disorders.
Read article »

5 questions on dengue vaccine analysis

Fred Hutchinson Cancer Research
June 20, 2018
Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines.
Read article »

DNA apps promise deeper insights for consumers – but at what cost?

The Conversation
May 21, 2018
What genetic and personal information are people exposing when they upload information to third-party sites? There is no blanket answer according to UW Biostatistics Research Scientist and PhD Candidate Sarah Catherine Nelson.
Read article »

School of Public Health Researchers Take Part in Largest-Ever Genetic Study of Stroke

SPH News, April 3, 2018
April 3, 2018
Co-authors include UW Biostat researchers Kenneth Rice, Cathy Laurie, Quenna Wong and Tracy Bartz as well as other UW School of Public Health scientists
Read article »

Oral Cholera Vaccine May Miss the Mark for Younger Children

SPH News, March 29, 2018
March 29, 2018
An international group of researchers used the trial data to compare vaccine efficacy and cholera risk between three different age groups: children younger than 5 years, 5 to under 15 years, and those 15 years and older. The research team included biostatisticians from the University of Washington School of Public Health and Fred Hutchinson Cancer Research Center.
Read article »

Pages